Data / Form D filings / Dermelle, LLC
Dermelle, LLC: Form D filings
Dermelle, LLC, a biotechnology company in Columbia, MO, filed 4 Form D notices with the SEC between 2012 and 2014. The latest, on November 3, 2014, reports $2 million sold of a $2 million offering to 28 investors.
Find out what Dermelle, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1601 S PROVIDENCE ROAD, Columbia, MO, 65211
- Phone
- (501) 339-7962
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Missouri
- Year incorporated
- 2009
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1556301
The full lists. Form D filings in Missouri: 379 rows, $18.95, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 3, 2014 | Amendment | $2,018,173 | $2,018,173 | $0 | 28 | May 5, 2013 | sec.gov |
| Nov 3, 2014 | Amendment | $2,018,173 | $2,018,173 | $0 | 28 | May 5, 2013 | sec.gov |
| Jul 23, 2013 | Amendment | $6,500,000 | $920,427 | $5,579,573 | 8 | Yet to occur | sec.gov |
| Sep 13, 2012 | New notice | $6,500,000 | $0 | $6,500,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Alan Grant | Director | |
| Anthony Nathaniel Harris | Director | |
| David Burton Keller | Director | |
| Sheila Ann Grant | Executive Officer | |
| Charles Alan Weatherstone | Director | |
| Anna Magdalena Lundvall | Executive Officer, Director | |
| Robert J Brooks | Director | |
| Dale Paul DeVore | Executive Officer | |
| Luis Raul Jimenez | Executive Officer, Director | |
| Guy Francois Bouchard | Director | |
| Rebecca Jane Rone-McCrate | Director |
Every Form D from the week of Nov 3, 2014 · All recent filings in Missouri · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Dermelle, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.